Pages:
Name Poster Topics Locations Session Tags
PCN126: DIRECT COST STUDY OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT) FOR RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM THE FRENCH HOSPITAL PERSPECTIVE CANCER - Cost Studies D19 Research Posters - V - Wednesday Cancer, Hematological/Blood
PCN127: DIRECT HEALTHCARE COSTS BY TREATMENT AMONG PATIENTS WITH MERKEL CELL CARCINOMA (MCC) IN THE UNITED STATES CANCER - Cost Studies D20 Research Posters - V - Wednesday Cancer
PCN128: COSTS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL), DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AND FOLLICULAR LYMPHOMA (FL) – A RETROSPECTIVE ANALYSIS OF JAPANESE CLAIMS DATA CANCER - Cost Studies D21 Research Posters - V - Wednesday Cancer
PCN129: TREATMENT COSTS AND PROGRESSION-FREE SURVIVAL OF DVD AND KRD REGIMENS SEQUENCES IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM CANCER - Cost Studies D22 Research Posters - V - Wednesday Cancer, Hematological/Blood
PCN130: COST ASSOCIATED WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) – A RETROSPECTIVE CLAIMS DATA ANALYSIS IN GERMANY CANCER - Cost Studies D23 Research Posters - V - Wednesday Cancer
PCN131: ASSESSING THE REAL-WORLD COST OF CARE IN PATIENTS WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER (MTNBC) IN THE UNITED STATES CANCER - Cost Studies D24 Research Posters - V - Wednesday Cancer
PCN132: WITHDRAWN CANCER - Cost Studies D25 Research Posters - V - Wednesday Cancer
PCN133: THE SOCIETAL IMPACT OF OBINUTUZUMAB IN THE FIRST LINE TREATMENT OF PATIENTS WITH FOLLICULAR LYMPHOMA IN GERMANY CANCER - Cost Studies D26 Research Posters - V - Wednesday Cancer
PCN134: USE OF LIQUID BIOPSY IN METASTATIC NON-SMALL CELL LUNG CANCER WITH EGFR MUTATION: A COST CONSEQUENCE ANALYSIS. CANCER - Cost Studies D27 Research Posters - V - Wednesday Cancer
PCN135: DOES PATIENT SELECTION CRITERIA TRANSLATE INTO COST SAVINGS IN PATIENTS WITH ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER CHEMOTHERAPY FAILURE IN SPAIN? CANCER - Cost Studies D28 Research Posters - V - Wednesday Cancer
PCN136: A COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA IN CANADA CANCER - Cost Studies D29 Research Posters - V - Wednesday Cancer, Urinary/Kidney
PCN137: THE ECONOMIC EVALUATION OF IMATINIB COMBINED WITH CHEMOTHERAPY FOR PEDIATRIC PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN CHINA CANCER - Cost Studies D30 Research Posters - V - Wednesday Cancer, Health-Children
PCN138: COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB IN PATIENTS WITH PREVIOUSLY TREATED LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER IN ENGLAND CANCER - Cost Studies D31 Research Posters - V - Wednesday Cancer
PCN139: COST-EFFECTIVENESS ANALYSIS OF PEMBROLIZUMAB FOR PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER WHO ARE INELIGIBLE FOR CISPLATIN-CONTAINING CHEMOTHERAPY IN ENGLAND CANCER - Cost Studies D32 Research Posters - V - Wednesday Cancer
PCN140: COST-EFFECTIVENESS ANALYSIS OF ALECTINIB VS CRIZOTINIB IN FIRST LINE ANAPLASTIC LYMPHOMA KINASE POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER IN PORTUGAL CANCER - Cost Studies D33 Research Posters - V - Wednesday Cancer
PCN141: COST-EFFECTIVENESS ANALYSIS OF OBINUTUZUMAB FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA IN GREECE CANCER - Cost Studies D34 Research Posters - V - Wednesday Cancer
PCN142: COST-EFFECTIVENESS ANALYSIS OF INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN BULGARIA CANCER - Cost Studies D35 Research Posters - V - Wednesday Hematological/Blood
PCN143: HEALTH ECONOMIC EVALUATION OF BIOLOGIC AGENTS FOR METASTATIC COLORECTAL CANCER PATIENTS IN BRAZIL. CANCER - Cost Studies E1 Research Posters - V - Wednesday Cancer
PCN144: COST-EFFECTIVENESS OF CABOZANTINIB FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA AFTER FAILURE OF PRIOR THERAPY IN SOUTH KOREA CANCER - Cost Studies E2 Research Posters - V - Wednesday Cancer, Urinary/Kidney
PCN145: COST-EFFECTIVENESS OF NINTEDANIB FOR THE TREATMENT OF NON-SMALL LUNG CANCER IN PORTUGAL CANCER - Cost Studies E3 Research Posters - V - Wednesday Cancer
PCN146: INOTUZUMAB OZOGAMICIN IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LYMPHOCYTIC LEUKEMIA (ALL): ESTABLISHING A VALUE-BASED COST – PRELIMINARY RESULTS CANCER - Cost Studies E4 Research Posters - V - Wednesday Cancer
PCN147: COST-EFFECTIVENESS SIMULATION AND ANALYSIS OF COLORECTAL CANCER SCREENING IN SHANGHAI POPULATION, CHINA: COMPARISON BETWEEN URBAN AND RURAL RESIDENTS CANCER - Cost Studies E5 Research Posters - V - Wednesday Cancer
PCN148: COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB COMPARED TO TREATMENT OPTIONS FOR ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) AFTER PRIOR CHEMOTHERAPY - UPDATED RESULTS CANCER - Cost Studies E6 Research Posters - V - Wednesday Cancer, Respiratory Disorders (including Chronic Obstructive Pulmonary Disease [COPD])
PCN149: COST-EFFECTIVENESS OF BRCA1/2 MUTATION PROFILING TO TARGET OLAPARIB USE IN PATIENTS WITH METASTATIC BREAST CANCER IN JAPAN CANCER - Cost Studies E7 Research Posters - V - Wednesday Cancer
PCN150: COST-EFFECTIVENESS ANALYSIS OF PHARMACOKINETIC-GUIDED (PK) 5-FLUOROURACIL (5-FU) DOSING WHEN COMBINED WITH LEUCOVORIN, IRINOTECAN AND OXALIPLATIN (FOLFIRINOX) CHEMOTHERAPY FOR ADVANCED PANCREAS CANCER CANCER - Cost Studies E8 Research Posters - V - Wednesday Cancer